Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

BioCorRx (BICX) Depreciation & Amortization (IS) (2016 - 2025)

BioCorRx (BICX) has disclosed Depreciation & Amortization (IS) for 15 consecutive years, with -$124804.0 as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (IS) fell 1059.74% to -$124804.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $44002.0 through Dec 2025, up 32.76% year-over-year, with the annual reading at $44003.0 for FY2025, 32.76% up from the prior year.
  • Depreciation & Amortization (IS) hit -$124804.0 in Q4 2025 for BioCorRx, down from $71986.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $71986.0 in Q3 2025 to a low of -$124804.0 in Q4 2025.
  • Historically, Depreciation & Amortization (IS) has averaged $9786.6 across 5 years, with a median of $6862.5 in 2021.
  • Biggest YoY gain for Depreciation & Amortization (IS) was 972.18% in 2025; the steepest drop was 1059.74% in 2025.
  • Year by year, Depreciation & Amortization (IS) stood at $6863.0 in 2021, then fell by 0.01% to $6862.0 in 2022, then decreased by 2.14% to $6715.0 in 2023, then skyrocketed by 93.66% to $13004.0 in 2024, then tumbled by 1059.74% to -$124804.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (IS) for BICX at -$124804.0 in Q4 2025, $71986.0 in Q3 2025, and $71977.0 in Q2 2025.